Do Adults Need an RSV Vaccine Every Year?

0
0

RSV vaccinations are not currently recommended every year for adults. In the United States, eligible adults are advised to get one dose, not a dose each RSV season. Protection can last beyond a year, although it wanes, and researchers are still evaluating whether another dose would provide enough additional benefit to recommend revaccination.

Why RSV Vaccinations Aren’t Automatically Annual

RSV often circulates seasonally, but that does not mean its vaccine must be repeated each season. The schedule depends on how long protection lasts and whether another dose improves protection enough to justify giving it. RSV vaccines are relatively new, so evidence on later seasons and repeat doses is still developing.

For two vaccines, GSK’s Arexvy and Pfizer’s Abrysvo, clinical-trial data showed protection against symptomatic lower respiratory tract disease lasting at least 23 months and 16 months, respectively, with some waning over time. Those are different follow-up periods, not a head-to-head comparison. The US Centers for Disease Control and Prevention (CDC) says studies of real-world effectiveness in the second year after vaccination are underway.

For Moderna’s mResvia, CDC reports trial efficacy against symptomatic RSV of about 80% in the first four months, 56% during the first year, and 34% through 18 months. These figures describe protection against a particular trial outcome; they do not mean that everyone loses protection at the same rate or that protection ends after a set date.

Real-world data also vary by study and outcome. In the Community Vaccine Effectiveness (CoVE) observational study, researchers followed 281 adults aged 60 and older in Michigan from August 2023 to March 2024; 14 tested positive for RSV. The number of cases was too small to give a precise estimate of vaccine effectiveness. The study offers an early community snapshot, not a basis for deciding when an individual should get another dose.

What Repeat-Dose Guidance Says In The US

CDC currently recommends a single dose for adults aged 75 and older, and for adults aged 50–74 who are at increased risk of severe RSV illness. Examples of risk factors include chronic lung or heart conditions, immune compromise, severe obesity, and residence in a long-term care facility. Check current CDC guidance or ask a clinician whether your health history meets the criteria.

CDC says eligible adults who have already received an RSV vaccine should not currently get another dose each year. The agency is monitoring vaccine effectiveness and safety, and will reconsider whether additional doses are useful as more later-season data become available. If you are eligible but unvaccinated, CDC says vaccination can be given at any time of year; in most of the continental US, late summer or early fall—usually August through October—is timed ahead of the season.

How Guidance Differs Outside The US

Product authorization and a national vaccination recommendation are not the same thing. A vaccine may be authorized for a broad age group, while a country’s public programme sets narrower age or risk criteria, or different rules for funding. A review of RSV prevention reported that Arexvy was authorized for older adults aged 60 and over in the US, EU, UK, and Australia. That licensing information alone does not establish who qualifies for a publicly funded dose in each place today.

The US recommendation above is a single-dose schedule. In the EU, national decisions are made by individual member states, so eligibility and access may differ between countries. UK and Australian programme criteria also need to be checked against current national guidance; a broad product licence should not be treated as proof that you qualify for a publicly funded vaccination. If you live outside the US, ask your local health service or clinician about the current age and risk criteria—and whether a repeat dose is recommended where you live.

For more on the one-dose question, see our guide to RSV vaccination for older adults. If you have a condition that may increase your risk, or are unsure whether you have had an RSV vaccine before, a clinician can help you check your records and current local advice.